Understanding the Landscape of HIV Vaccine & Cure Research - a Funders' Briefing

Thursday, March 29th, 3:00 - 4:30 pm ET


***If you have trouble with the recording (seeing slides or hearing the presentation). Please refresh your window. If you are a MAC user, right click on the screen, press "settings". On the Adobe display box, click the "display" tab at the left and uncheck the box that says "enable hardware." You will need to refresh your screen.***

***The recording slides freeze after Mitchell Warren. You can download the final two slide sets below to follow along with the audio.***

The Thai Phase III HIV vaccine clinical trial (also known as RV144) and the Berlin Patient (Timothy Ray Brown) gave us proof of concept that a vaccine and a cure are possible, but they are not yet within reach. What is happening across the HIV/AIDS research field now that holds promise? What are the vaccine and cure strategies? What are the scientific, financial and political challenges?

Timed on the heels of the 19th Conference on Retroviruses and Opportunistic Infections (CROI), this discussion among advocates, researchers and funders explored the scope of current research and discuss real and practical steps to move the field closer to ending AIDS. 


  • Pat Fast, Chief Medical Officer, IAVI Download presentation
  • Dr. Paula Cannon, Associate Professor, Molecular Microbiology & Immunology, Pediatrics, Biochemistry & Molecular Biology, USC Keck School of Medicine Download presentation
  • Kate Krauss, Executive Director and Founder, AIDS Policy Project Download presentation
  • Mitchell Warren, Executive Director, AVAC Download presentation
  • Rowena Johnston, Vice President and Director, Research, amfAR  (Moderator)